-
EU chief says Kremlin imposing 'digital Iron Curtain' on Russians
-
South Korean court hikes ex-president's sentence for obstructing justice
-
Adidas reports higher profits but warns of 'volatile' climate
-
TotalEnergies first-quarter profits surge amid Middle East war
-
Sri Lanka government 'temporarily' takes over cricket board
-
EU finds Meta failing to keep under-13s off Facebook, Instagram
-
King Charles to stress UK-US cultural, trade ties in New York
-
US judge orders Purdue Pharma to pay billions ahead of bankruptcy
-
'Jurassic Park' star Sam Neill says cancer-free after gene therapy
-
US opioid crisis victims testify at emotional Purdue Pharma hearing
-
Australian climber on record sea-to-summit Everest bid
-
Indian opposition slams Nicobar megaport plan as 'destruction'
-
Pentagon chief to testify on Iran war, peace efforts stall
-
Anxiety, resentment around AI spur violence against tech's figureheads
-
Mercedes-Benz profit slides amid cutthroat Chinese market
-
Hungary's Magyar to push post-Orban EU reset on Brussels visit
-
Going online helps Pakistan's women doctors back to work
-
Wembanyama's Spurs advance in NBA playoffs, 76ers stay alive
-
Tropical forest loss eases after record year: researchers
-
Tigres edges Nashville in CONCACAF Champions Cup first leg
-
New Zealand officials reject statue remembering Japan's sex slaves
-
King Charles, Trump toast ties despite Iran tensions
-
Japan cleaner goes viral with spa-like service for plushies
-
What we learned from cycling's Spring Classics
-
Villa, Forest revive European glory days in semi-final showdown
-
Remarkable, ramshackle Rayo chasing Conference League dream amid chaos
-
Unbeaten records on the line for Inoue-Nakatani superfight in Tokyo
-
Cheaper, cleaner electric trucks overhaul China's logistics
-
Stocks swing, oil edges up with Iran war peace talks stalled
-
Europe climate report signals rising extremes
-
Sexual violence in Sudan triggers mental health crisis: UN
-
The loyal, lonely keepers of Sudan's pyramids
-
'Final mission': NZ name star trio for T20 World Cup defence
-
Embiid-led 76ers beat Boston to avoid NBA playoff exit
-
An experimental cafe run by AI opens in Stockholm
-
Exiting fossil fuels key to energy security: nations at Colombia talks
-
Jerome Powell: Fed chair who stood up to Trump set to finish tenure on top
-
All eyes on Powell with US Fed expected to hold rates steady
-
Pentagon makes deal to expand use of Google AI: reports
-
King Charles urges US-UK reset in speech to Trump
-
France unveils plan to ditch all fossil fuels by 2050
-
World Cup to get cash boost as FIFA unveils red card crackdown
-
Grande Portage Resources Initiates Full Scale Geochemical Characterization Program and Backfill Testwork for the New Amalga Gold Project
-
LIV Golf postpones New Orleans event
-
Luis Enrique predicts more thrills in return leg after PSG beat Bayern in classic
-
AI fakes of accused US press gala gunman flood social media
-
Ex-FBI chief Comey charged with threatening Trump's life in Instagram post
-
PSG edge Bayern in nine-goal Champions League semi-final epic
-
Baptiste ends Sabalenka's Madrid title defence
-
Late-night buzz returns to Cairo as war-fuelled energy curbs ease
US judge orders Purdue Pharma to pay billions ahead of bankruptcy
A US federal judge on Tuesday sentenced OxyContin-maker Purdue Pharma to pay billions of dollars over its role in the opioid crisis, ahead of upcoming bankruptcy proceedings and its dissolution.
The criminal sentencing caps off years of legal battles and paves the way for Purdue and its former owners, the Sackler family, to pay more than $8 billion as part of a settlement.
Between 1999 and 2023, around 806,000 people died from opioid overdoses in the United States, according to the Centers for Disease Control and Prevention.
Purdue and other opioid makers and distributors are accused of encouraging free-wheeling prescription of painkillers like OxyContin starting in the 1990s, while hiding how addictive the drugs are.
Last year, several US states reached a settlement with Purdue and the Sackler family, with a bankruptcy plan that will see funds routed to affected communities and individuals.
The total amount to be paid in fines, forfeitures and penalties surpasses $8 billion.
The company is set to be dissolved on May 1, with the remnants becoming Knoa Pharma, a public benefit company that will provide opioid use disorder treatments and overdose reversal medicines.
For more than six hours on Tuesday, US Judge Madeline Cox Arleo listened to dozens of victims and their families testify about the impact Purdue Pharma and the opioid epidemic had on them.
She then ordered Steve Miller, Purdue Pharma's board chair, to apologize to them.
During the proceedings to resolve a Department of Justice probe and clear the way for the settlement, Arleo read the names of more than 200 victims who had submitted written statements before the hearing.
"These people are not statistics in an epidemiological study," she said, adding that the testimonies were "heartbreaking."
The judge also apologized on behalf of the US government, saying it had "failed" to protect the public from Purdue Pharma, whose practices were "driven by greed" and had a "corporate strategy much like a criminal enterprise."
While many testifying on Tuesday urged the settlement agreement to be rejected -- in part because it protects the Sackler family from criminal prosecution -- Arleo called it the "best route I see among the options before me."
She urged the lawyers handling the bankruptcy proceedings to honor their promises of compensation.
For many people, opioid addiction begins with prescribed pain pills, such as OxyContin, before they increase their consumption and eventually turn to illicit drugs such as heroin and fentanyl, an extremely powerful synthetic opioid.
O.Bulka--BTB